RELAX: Sildenafil Falls Short in Preserved-EF Heart FailureRELAX: Sildenafil Falls Short in Preserved-EF Heart Failure

A lot of laboratory work, observational data, and small studies point to PDE-5 inhibition as a promising therapeutic approach in heart failure with preserved ejection fraction; it may still be, but a multicenter randomized trial found little to support it and a few cautions along the way. Heartwire
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news